Targeting the Warburg Effect in Cancer: Where Do We Stand?
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic concepts and pharmacological strategies without systematic review methodology or primary clinical trial data.
PubMed 38542116 · doi:10.3390/ijms25063142
What was done
This narrative review summarizes the current understanding of the Warburg effect (aerobic glycolysis producing lactate in the presence of oxygen) in cancer. The authors examine how lactate accumulation and acidic tumor microenvironments contribute to macrophage reprogramming and T-cell impairment, review pharmacological strategies targeting glycolytic enzymes, and assess the Warburg effect's utility in early cancer diagnosis.
What was found
The abstract reports no numerical metrics, effect sizes, or study counts. It qualitatively notes that the Warburg effect promotes tumor progression and immunosuppression, outlines difficulties in achieving therapeutic efficacy when targeting glycolytic enzymes, and highlights lactate disruption as a strategy to enhance anti-tumor immunity.
Why it matters
Targeting tumor glycolytic pathways offers a dual approach to inhibit cancer cell metabolism directly while reversing immunosuppressive microenvironmental conditions.
Limits
The paper is a non-systematic narrative review providing no primary clinical data, quantitative outcomes, or details regarding the number of studies evaluated.
Cited by
- contradicts Mitochondria in cancer cells are invariably dysfunctional, particularly in their capacity for oxidative phosphorylation.